1.
Erratum for: Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis. Clinics. 2021;76:e1857err. doi:10.6061/clinics/2021/e1857err